Please try another search
A1M Pharma AB is a Sweden-based company, which is active within the healthcare sector. The Company conducts development and commercialization of treatment and diagnostics based on the alpha-1-microglobulin (A1M) protein. The protein serves as a radical inhibitor, an antioxidant, a protector against free hemoglobin and a tissue repairer. A1M is a candidate for different therapeutic and diagnostic uses, such as alleviation of autoimmune diseases and stroke treatment. The Company works with the protein and conducts research at the Biomedical Center in Lund University, Sweden. The Company develops a drug for intravenous treatment of preeclampsia, a condition that can occur during pregnancy and can contribute to premature deliveries.
Name | Age | Since | Title |
---|---|---|---|
Michael J. Brownstein | - | - | Member of Scientific Board |
Christopher Redman | - | - | Member of Scientific Board |
Johannes Hulthe | 51 | 2019 | Independent Director |
Anthony James Kettle | - | - | Member of Scientific Board |
Johan Bygge | 65 | 2021 | Independent Chairman of the board |
Goran Forsberg | 58 | 2019 | Independent Director |
József Balla | - | - | Member of Scientific Board |
Gunvor Ekman Ordeberg | - | - | Member of Scientific Board |
Henning Schneider | - | - | Member of Scientific Board |
Lars Hockenstrom | 65 | 2019 | Independent Director |
Fredrik Lehmann | 47 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review